CEN/TC 206
| Registration number (WIID) | Project No. | Title | Status |
|---|---|---|---|
| 78994 | EN ISO 10993-17:2023/A1:2025 | Biological evaluation of medical devices - Part 17: Toxicological risk assessment of medical device constituents - Amendment 1 (ISO 10993-17:2023/Amd 1:2025) | Standarts spēkā |
| 78989 | EN ISO 10993-12:2021/A1:2025 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials - Amendment 1 (ISO 10993 12:2021/Amd 1:2025) | Standarts spēkā |
| 75885 | EN ISO 10993-7:2026 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals (ISO 10993-7:2026) | Standarts spēkā |
| 67095 | LVS EN ISO 10993-12:2021 | Biological evaluation of medical devices - Part 12: Sample preparation and reference materials (ISO 10993-12:2021) | Standarts spēkā |
| 80820 | EN ISO 10993-5:2009/A11:2025 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity | Standarts spēkā |
| 22089 | EN ISO 10993-5:2009 | Biological evaluation of medical devices - Part 5: Tests for in vitro cytotoxicity (ISO 10993-5:2009) | Standarts spēkā |
| 60724 | LVS EN ISO 10993-16:2018 | Biological evaluation of medical devices - Part 16: Toxicokinetic study design for degradation products and leachables (ISO 10993-16:2017) | Standarts spēkā |
| 77182 | EN ISO 14155:2026 | Clinical investigation of medical devices for human subjects - Good clinical practice (ISO 14155:2026) | Standarts spēkā |
| 64034 | LVS EN ISO 10993-7:2009/A1:2022 | Biological evaluation of medical devices - Part 7: Ethylene oxide sterilization residuals - Amendment 1: Applicability of allowable limits for neonates and infants (ISO 10993-7:2008/Amd 1:2019) | Standarts spēkā |
| 65727 | LVS EN ISO 10993-4:2018 | Biological evaluation of medical devices - Part 4: Selection of tests for interactions with blood (ISO 10993-4:2017) | Standarts spēkā |
Displaying 41-50 of 198 results.